Peninsula Eye Centre- Clinical Update March 2020
Date: 17/03/2020
Venue: The Rocks 1 Schnapper Point Drive, Mornington, VIC, 3931
Provider: Peninsula Eye Centre
Contact: Eva Dodwell, [E] edodwell@vistaeyes.com.au, [P] 03 8532 5000
Learning Objectives
- To identify the ocular signs and symptoms that could be associated with medical emergencies.
- To understand the appropriate referral pathway for patients presenting with potentially life threatening conditions.
- To recognise features of benign versus malignant eyelid lesions.
- To understand the process a patient will go through during and after surgery for eyelid lesions.
- To discuss current limitations in the management of patients with neovascular AMD.
- To introduce the newest anti-VEGF agent for neovascular AMD- Brolucizumab (Beovu).
- To discuss factors associated with successful collaborative care in patients with glaucoma.
- To highlight possible limitations of a shared-care glaucoma arrangement.
Max points awarded: 3.67
Session Information
| Name |
|---|
| Signs and symptoms not to miss |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| More oculoplastics cases - benign and malignant eyleid lesions & reconstruction techniques |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| Co-Management in Glaucoma |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.00 |
| Name |
|---|
| Introducing a novel treatment for neovascular AMD |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 0.67 |